Literature DB >> 16093922

Increased myocardial repolarization lability and reduced cardiac baroreflex sensitivity in individuals with high-normal blood pressure.

Anna Myredal1, Sinsia Gao, Peter Friberg, Gert Jensen, Lars Larsson, Mats Johansson.   

Abstract

BACKGROUND: Recent guidelines for the management of arterial hypertension have proposed that, to prevent cardiovascular disease, lifestyle modifications are required even in the case of high-normal blood pressure (HNBP).
OBJECTIVE: To assess myocardial repolarization and spontaneous cardiac baroreflex sensitivity (BRS) in newly diagnosed and never-treated individuals. DESIGN AND PARTICIPANTS: We studied healthy individuals with HNBP according to the 2003 European Society of Hypertension-ESC guidelines and, for comparison, patients with renovascular hypertension (RVH) and healthy individuals with normal blood pressure (NBP). MAIN OUTCOME MEASURES: Electrocardiogram and beat-to-beat blood pressure were recorded and spontaneous cardiac baroreflex sensitivity and the temporal QT interval variability index (QTVI) were calculated.
RESULTS: Individuals with HNBP had increased QTVI values compared with those with NBP (-1.23 +/- 0.37 compared with -1.52 +/- 0.26; P < 0.05), whereas patients with RVH had additionally increased QTVI values that were greater than those in healthy individuals with NBP or HNBP (-0.81 +/- 0.75; P < 0.05 compared with both groups). BRS was reduced in both groups of individuals with increased blood pressures compared with NBP (8.2 +/- 4.1 ms/mmHg for individuals with HNBP, 6.1 +/- 4.3 ms/mmHg for patients with RVH and 10.8 +/- 3.5 ms/mmHg for NBP; P < 0.05 for both).
CONCLUSION: In otherwise healthy individuals, even a moderate blood pressure increase is associated with increased myocardial repolarization lability and reduced baroreflex sensitivity (BRS). Patients with RVH have an additionally increased QTVI, with values similar to those reported in congestive heart failure. Future studies are needed to establish the value of QTVI and BRS measurements among individuals with HNBP in predicting the risk of progression to hypertension and end-organ damage.

Entities:  

Mesh:

Year:  2005        PMID: 16093922     DOI: 10.1097/01.hjh.0000179762.93291.94

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death.

Authors:  Deeptankar DeMazumder; Worawan B Limpitikul; Miguel Dorante; Swati Dey; Bhasha Mukhopadhyay; Yiyi Zhang; J Randall Moorman; Alan Cheng; Ronald D Berger; Eliseo Guallar; Steven R Jones; Gordon F Tomaselli
Journal:  Europace       Date:  2016-04-04       Impact factor: 5.214

2.  HIV Infection Is Associated With Variability in Ventricular Repolarization: The Multicenter AIDS Cohort Study (MACS).

Authors:  Amir S Heravi; Lacey H Etzkorn; Jacek K Urbanek; Ciprian M Crainiceanu; Naresh M Punjabi; Hiroshi Ashikaga; Todd T Brown; Matthew J Budoff; Gypsyamber D'Souza; Jared W Magnani; Frank J Palella; Ronald D Berger; Katherine C Wu; Wendy S Post
Journal:  Circulation       Date:  2019-11-11       Impact factor: 29.690

3.  QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.

Authors:  Mathias Baumert; Alberto Porta; Marc A Vos; Marek Malik; Jean-Philippe Couderc; Pablo Laguna; Gianfranco Piccirillo; Godfrey L Smith; Larisa G Tereshchenko; Paul G A Volders
Journal:  Europace       Date:  2016-01-27       Impact factor: 5.214

4.  Influence of acute progressive hypoxia on cardiovascular variability in conscious spontaneously hypertensive rats.

Authors:  Mitsutaka Sugimura; Yohsuke Hirose; Hiroshi Hanamoto; Kenji Okada; Aiji Boku; Yoshinari Morimoto; Kunitaka Taki; Hitoshi Niwa
Journal:  Auton Neurosci       Date:  2008-07-02       Impact factor: 3.145

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.